Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/2012
12/27/2012WO2012176212A1 Carrier based nanogel formulation for skin targeting.
12/27/2012WO2012175996A2 Drug delivery formulations
12/27/2012WO2012175879A1 Film-forming composition, and use thereof for treating herpes
12/27/2012WO2012175775A1 Phosphodiesterase inhibitors applied via the transvaginal route for the treatment of infertility
12/27/2012WO2012175749A1 Delivery of viral agents
12/27/2012WO2012175748A1 Micro- or nanoparticles comprising a biodegradable polyesteramide copolymer for use in the delivery of bioactive agents
12/27/2012WO2012175746A1 New biodegradable polyesteramide copolymers for drug delivery
12/27/2012WO2012175737A1 Active ingredient matrix
12/27/2012WO2012175642A1 Peptide prodrugs
12/27/2012WO2012175641A1 Formulations of fluorinated stilbene suitable for pet imaging
12/27/2012WO2012175617A1 Diblock copolymer
12/27/2012WO2012175608A1 Method for manufacturing hydroxyethyl starch derivatives
12/27/2012WO2012175554A1 Prodrugs of (1s,9s)-9-[[(1s)-1-carboxy-3-phenylpropyl]amino]octahydro-10-oxo-6h-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid and their use in transdermal therapeutic systems
12/27/2012WO2012175508A1 Removal of target cells by circulating virus-specific cytotoxic t-cells using mhc class i comprising complexes
12/27/2012WO2012175434A1 Pharmaceutical formulations comprising vestipitant
12/27/2012WO2012175223A1 Cathepsin-binding compounds bound to a carrier and their diagnostic use
12/27/2012WO2012174784A1 Cefuroxime axetil tablet and direct all-powder compression method thereof
12/27/2012WO2012174731A1 Method and improved pharmaceutical composition for improving the absorption of an ester prodrug
12/27/2012WO2012149265A3 Tolerogenic synthetic nanocarriers to reduce cytotoxic t lymphocyte responses
12/27/2012WO2012142410A3 Redox responsive polymeric nanocapsules for protein delivery
12/27/2012WO2012142245A3 Peptide mimetic ligands of polo-like kinase 1 polo box domain and methods of use
12/27/2012WO2012137150A3 Cell penetrating peptides for intracellular delivery of molecules
12/27/2012WO2012135588A3 Methods of treating serosal cancer
12/27/2012WO2012135422A3 Thermo-sensitive, mucoadhesive or dermoadhesive, and penetration-enhancing formulations for topical delivery of therapeutics
12/27/2012WO2012134540A3 Injectable synthetic pur composite
12/27/2012WO2012124998A3 Bio-pin
12/27/2012WO2012107908A3 Nts-polyplex nanoparticles system for gene therapy of cancer
12/27/2012WO2012093137A9 Liposome formulation suitable for treating or preventing tuberculosis
12/27/2012WO2012031250A3 Compositions for labeling nerves and methods of use
12/27/2012US20120329884 Food Ingredients From Stevia Rebaudiana
12/27/2012US20120329883 Polyurethane Elastomers
12/27/2012US20120329882 pH Responsive Self-Heating Hydrogels Formed By Boronate-Catechol Complexation
12/27/2012US20120329850 Methods for treating retinopathy with extended therapeutic effect
12/27/2012US20120329817 Mucosal bioadhesive slow release carrier for delivering active principles
12/27/2012US20120329766 Formulation
12/27/2012US20120329765 Medicinal targeted local lipolysis
12/27/2012US20120329738 Water Soluble Drug-Solubilizer Powders and Their Uses
12/27/2012US20120329670 Epitope testing using soluble hla
12/27/2012US20120329655 Adjuvants and methods of using them
12/27/2012US20120328718 Pharmaceutical compositions
12/27/2012US20120328706 Polymer particle delivery compositions and methods of use
12/27/2012US20120328702 Nanoparticle compositions
12/27/2012US20120328697 Controlled Release Solid Dose Forms
12/27/2012US20120328694 Therapeutic agent for fibroid lung
12/27/2012US20120328679 Solid pharmaceutical dispersions with enhanced bioavailability
12/27/2012US20120328677 Active Agent Formulations, Methods of Making, and Methods of Use
12/27/2012US20120328666 Oral delivery of peptide pharmaceutical compositions
12/27/2012US20120328664 Liquid formulations
12/27/2012US20120328639 Immunogenic lhrh compositions and methods relating thereto
12/27/2012US20120328634 Immunoconjugates with an Intracellularly-Cleavable Linkage
12/27/2012US20120328555 Drug delivery of temozolomide for systemic based treatment of cancer
12/27/2012US20120328539 Thickener Or Gellant For Oil Materials, Gel Composition Comprising Same, And Method Of Producing Cosmetic Material Or Topical Agent
12/27/2012US20120328538 Glycerine Based Jelly Compositions
12/27/2012US20120328525 Nanoparticle compositions and components thereof
12/27/2012US20120328523 Polyhydroxyalkanoates for in vivo applications
12/27/2012CA2846498A1 Transvaginal phosphodiesterase inhibitors for infertility treatment
12/27/2012CA2844367A1 Method and improved pharmaceutical composition for improving the absorption of an ester prodrug
12/27/2012CA2840224A1 Treatment of proteinopathies
12/27/2012CA2840215A1 Conjugate-based antifungal and antibacterial prodrugs
12/27/2012CA2840142A1 Drug delivery formulations
12/27/2012CA2839986A1 Targeting the neuromuscular junction for treatment
12/27/2012CA2839961A1 Formulations of fluorinated stilbene suitable for pet imaging
12/27/2012CA2839917A1 Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
12/27/2012CA2839841A1 New biodegradable polyesteramide copolymers for drug delivery
12/27/2012CA2839822A1 Ophthalmic solution containing hyaluronic acid or salt thereof and propylene glycol
12/27/2012CA2839819A1 Hydrophobic polymer compound having anticoagulant effect
12/27/2012CA2839563A1 Anti-alpha synuclein binding molecules
12/27/2012CA2839526A1 Micro- or nanoparticles comprising a biodegradable polyesteramide copolymer for use in the delivery of bioactive agents
12/27/2012CA2839473A1 Film-forming composition, and use thereof for treating herpes
12/27/2012CA2837784A1 Method for manufacturing hydroxyethyl starch derivatives
12/27/2012CA2836927A1 Novel maytansinoid derivatives with peptide linker and conjugates thereof
12/27/2012CA2835772A1 Removal of target cells by circulating virus-specific cytotoxic t-cells using mhc class i comprising complexes
12/26/2012EP2537866A1 Hydroxyethyl starch derivatives, method for manufacturing the same and therapeutical uses thereof
12/26/2012EP2537865A1 Novel dextrin fatty acid ester that does not cause gelation of liquid oil, and uses thereof
12/26/2012EP2537533A2 Antitumoral bioconjugates of hyaluronic acid or its derivatives obtained by indirect chemical conjugation
12/26/2012EP2537532A1 Cathepsin-binding compounds bound to a nanodevice and their diagnostic and therapeutic use
12/26/2012EP2537531A2 Composition for percutaneous administration of tolterodine with reduced skin irritation
12/26/2012EP2537530A1 Radiation therapy agent
12/26/2012EP2537515A1 Dietetic product for treating mitochondrial dysfunctions
12/26/2012EP2537031A1 Compositions and methods for treating cancer
12/26/2012EP2536752A1 Conjugated proteins
12/26/2012EP2536744A1 Chimeric surface active proteins
12/26/2012EP2536691A1 Bifunctional chelating agents
12/26/2012EP2536434A2 Purification method
12/26/2012EP2536401A1 Doxylamine resinate complex
12/26/2012EP2536397A1 Solid pharmaceutical composition with enhancers and methods of preparing thereof
12/26/2012EP2536393A2 Test solvent for evaluating the compatibility of biologically active substances and graft copolymers
12/26/2012EP2536378A2 Disinfectant composition and its use in dental treatment
12/26/2012EP2536274A1 Skin disinfectant composition and methods for manufacturing and using
12/26/2012CN202620272U Diclofenac sodium sustained-release pellet
12/26/2012CN1843334B Method for promoting liposome encapsulation
12/26/2012CN102844367A 水凝胶 Hydrogels
12/26/2012CN102844077A A solid pharmaceutical composition for neutralizing stomach acid
12/26/2012CN102844046A Exosomes derived from reticulocytes infected with plasmodium sp., method for obtaining them and uses thereof
12/26/2012CN102844036A Methods and compositions for in vitro and in vivo chondrogenesis
12/26/2012CN102844034A Composition containing stabilized phosphatidylserine
12/26/2012CN102844026A Fungal nail treatment composition
12/26/2012CN102838751A Amphiphilic block copolymer self-assembled micelle based on molecular glue and purpose thereof
12/26/2012CN102838742A Polyether homopolymer and preparation method thereof
12/26/2012CN102838683A Low molecular weight (LMW) xanthan gum and preparation method thereof
1 ... 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 ... 1712